Fig. 7
From: PI3Kδ inhibition prevents IL33, ILC2s and inflammatory eosinophils in persistent airway inflammation
Schematic representation of the key inflammatory pathways involved in allergic pulmonary inflammation and their ablation by PI3Kδ inhibition and anti-IL5 antibody treatment